AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 97 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,395,000 | +71.6% | 51,895 | +103.2% | 0.34% | +44.1% |
| Q1 2018 | $813,000 | +194.6% | 25,544 | +250.4% | 0.24% | +223.3% |
| Q4 2017 | $276,000 | +232.5% | 7,290 | +116.6% | 0.07% | +217.4% |
| Q3 2017 | $83,000 | -20.2% | 3,365 | -33.3% | 0.02% | -17.9% |
| Q2 2017 | $104,000 | -21.2% | 5,045 | -17.2% | 0.03% | -20.0% |
| Q1 2017 | $132,000 | – | 6,095 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|